Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11072579 Treatment of cataplexy

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 30 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12128021 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
0
Edits on 16 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 16 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12115145 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 16 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12115144 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 16 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12115143 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 16 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12115142 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
0
Edits on 9 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12109186 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
0
Edits on 5 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 5 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11998639 Formulations of (R)-2-amino-3-phenylpropyl carbamate
0
Edits on 22 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 22 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11986455 Methods of providing solriamfetol therapy to subjects with impaired renal function
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 22 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11986454 Methods of providing solriamfetol therapy to subjects with impaired renal function
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 22 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11986451 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
0
Edits on 1 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 1 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11969404 Methods of providing solriamfetol therapy to subjects with impaired renal function
0
Edits on 12 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Jan, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11865098 Methods and compositions for treating excessive sleepiness
0
Edits on 3 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 3 Jan, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11857528 Methods of providing solriamfetol therapy to subjects with impaired renal function
0
Edits on 27 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11850228 Methods of providing solriamfetol therapy to subjects with impaired renal function
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11850227 Methods of providing solriamfetol therapy to subjects with impaired renal function
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11850226 Methods of providing solriamfetol therapy to subjects with impaired renal function
0
Edits on 13 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11839597 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11839599 Methods of providing solriamfetol therapy to subjects with impaired renal function
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11839598 Methods of providing solriamfetol therapy to subjects with impaired renal function
0
Edits on 12 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 12 Dec, 2023
Edits made to:
Article (+215 characters)
Article

Patent abstract

The present invention relates to a method of treating cataplexy in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.

Find more entities like US Patent 11072579 Treatment of cataplexy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.